The physical characteristics and performance attributes of absorbent gauze and spunlaced nonwovens used for medical/surgical applications are reviewed. Because the manufacturing lines for spunlacing are versatile and highly productive, nonwoven products from this process are highly engineered and may have superior performance characteristics relative to gauze products. Dressings made from spunlaced materials are rapidly gaining in the wound care products market, which was once exclusive to woven gauze. A few microscopic images and SEM photomicrographs of a gauze made with two dissimilar technologies are included to show structural differences between the two, which otherwise are difficult to detect visually.
Introduction
The primary use for woven and nonwoven medical/surgical materials is in wound care. Wounds have traditional been covered by gauze to absorb exudate, protect from external contamination and cushion from further trauma. Wounds may occur from trauma, burns or surgical procedures and produce varying amounts of wound exudates that provide an environment for infection and bacterial growth. Gauze in the form of sterile dressings, sponges and bandage rolls have been used for decades to cover, protect, absorb body fluids and support wounds.
While absorbent woven gauze has been widely used for wound care, the newer spunlaced nonwovens are an attractive alternative to woven gauze for medical/surgical use. Construction and salient features of both gauze and nonwoven materials will be discussed.
Woven Absorbent Gauze
Gauze has been the preferred material for the making of medical dressings, sponges and bandages for over a hundred years. "Absorbent Gauze" is described in the United States Pharmacopoeia (USP) [1] as follows: "Absorbent Gauze is cotton or a mixture of cotton and not more than 53%, by weight, of rayon, and is in the form of a plain weave cloth conforming to the standards set forth in USP."
Because gauze is converted into dressings and bandages for wound care, the standards of construction and chemical purity are well defined in the USP Absorbent Gauze monograph. [1] Absorbent gauze must meet specific standards of construction, chemical purity and absorbency to be labeled as USP gauze. Gauze is a thin, sheer-woven, open-mesh, low-count, plain weave, soft fabric. [2, 3] This fabric is manufactured by a textile process known as weaving. Weaving consists of interlacing the lengthwise warp yarns with the crossing or filling yarns. Figure 1 shows a plain weave cotton gauze USP Type III. As seen, cotton yarns are hairy. Because cotton warp yarns are subjected to considerable tension they are first coated with starch or other sizing to prevent the warp yarns from breaking during weaving. Twenty years ago, the typical cotton loom speed was 180 picks per COTTON WOVEN GAUZE  USP TYPE III 35 G/M 2 minute. This means that 180 filling yarns are interlaced with warp yarns each minute. For USP gauze type VIII with a thread count of 12 x 10 (i.e., 12 warp and 10 filling threads per inch) 18 inches (0.5 yard) of fabric can be woven in a minute. On the latest multisheds Sulzer Ruti M8300 airjet loom, for a maximum reeded width of 1,900 mm (75 inches) with capability of 2,800 picks per minute, 280 inches (7.7 yards) of fabric may be produces in a minute.
To improve productivity, the machine manufacturers are attempting to accelerate the speed of the looms and increase the width of the woven fabric. In the airjet field, the Sulzer Ruti's L5200 loom will have a reed space of 3,300 mm (130 inches). Among the conventional or single-shed machines, the Tsudakoma ZAX-390-4C-C8, at only 800 picks/minute, is often used because it is a very wide machine (3800 mm or 150 inches) with a reeded width of two cloths of 1,830 mm each, and a fill-insertion rate of 2,930 m/min. [4] Since weaving productivity is mainly a function of pick density, production capability of the looms will be relatively reduced for weaving gauze that has a density greater than 10 picks per inch. Performance of high-speed looms depends on good quality cotton yarns, since inferior quality yarns cause excessive breaks.
Gauze in the greige or loom state is nonabsorbent. Chemical processing steps of desizing, scouring and bleaching of gauze are necessary to make the fabric absorbent, soft and free from natural and added impurities. The preliminary step in the preparation of gauze for leaching consists of desizing. Desized fabric is subsequently scoured and bleached. Bleached gauze must meet specific standards of chemical purity (Table 1 ) to be labeled as USP gauze. (1); owf = on weight of the fiber Gauze bleaching by high volume healthcare product manufacturers is carried out in open-width on multi-beams in huge kiers. A few of these manufacturers have an additional advantage in that the converting operations (of making surgical gauze products, dressings, sponges and bandage rolls) packaging and sterilizing are at the same location (Savings in shipping costs). Smaller bleacheries carry out 4-to-6 layered gauze bleaching in conventional rope form. The rope of several layers of gauze is opened to full width on a water-mangle before drying.
In the following pages it will be shown that 15 or more highly productive Tsudakoma looms (or 220 typical 20 year-old looms) are required to match the production capability of a spunlacing operating at a modest speed of 100 meters per minute. The spunlacing lines are capable of operating at 350 meters per minute. Thus the economics of production are heavily in favor of spunlacing. Quality and versatility are also in favor of spunlacing. It has been realized that the conventional weaving of gauze for specific medical products may be best left to developing countries with low labor costs. Johnson & Johnson and Smith & Nephew decided to start a phase out of gauze production in favor of spunlaced nonwovens in 1991 and 1994, respectively, [5, 6] and will be sourcing woven gauze from the Far East. Another reason for the shift is that low labor rates and modern plants in Asian countries along with reasonable long-distance shipping costs give many commodity products made in developing countries a cost advantage over the U.S.-made gauze products. Despite all the technological advancements in nonwoven products, gauze products likely will always have an assured medical market. Doctors and nurses have developed procedures and techniques for using woven gauze products and tend to be reluctant to change. [7] Spunlaced Nonwovens During World War II, a shortage of gauze and other raw materials led engineers to search for new ways to manufacture lightweight fabrics. They sought production methods that were more efficient than weaving and less dependent on quality yarns. Researchers focused on producing textile fabrics from the fibrous webs that are created during the carding process. They strengthened the web with an adhesive binder to produce nonwoven fabrics. Later, they developed a nonwoven fabric made from a web that was strengthened by hydroentanglement without a binder. The term spunlaced nonwovens is also sometimes used because nonwovens that are formed by entangling fiber webs with water initially had lace like patterns.
During the past 10 years, fabrics based on hydroentanglement have reached sales and production levels that challenge the previous use of woven gauze. [7, 8, 9] Spunlaced fabrics often have better aesthetic and physical characteristics than traditional woven gauze products. They are safe, cost competitive and provide functional advantages not provided by gauze or to other types of nonwoven fabrics. Because spunlaced fabrics do not use yarns, they are often less expensive to manufacture than woven or knit fabrics.
In the hydroentanglement process, fine, high-speed, high-pressure waterjets impact a fibrous web. This causes the fibers to curl, entangle and knot each other. Figure 2 shows the structure of a spunlaced 100% cotton fabric (60g/m 2 ). Figures 3a and 3b show a 50/50 polyester/cotton spunlaced fabric, at two magnifications. Figures 4a and 4b show micrographs of a 100% polyester fabric at comparable two magnifications having an identical pattern as in Figure 3 .
Thus, binder-free nonwovens are produced for applications where chemicals are not desired, especially in hospital operating rooms. [10] Because the waterjets in spunlacing perforate the web, the product takes on a aesthetically pleasing woven appearance. This appearance can be controlled or changed by supporting the web on a perforated or patterned screen, plate or drum so that the fibers become entangled and the product assumes the pattern of these web supporting devices. [11, 12, 13, 14] Cotton, polyester, and rayon are the most frequently used fibers and they are often blended to obtain certain desired physical and functional characteristics. The broadening of the spunlacing market results essentially from technological improvements, and especially improvements in manufacturing costs [15] . Spunlaced fabrics made with bleached cotton are being produced around the world, with significant quantities produced in Japan. [16] The Japanese company Unitika manufactures a spunlaced cotton nonwoven called "Cottace." Production of Cottace has been 2000 tons per year [17] and Unitika is currently considering increasing production capacity by about 50%. [18] Spunlaced fabrics for medical devices are produced in the U.S. by DuPont, PGI, Veratec and others. Finished sponges and bandage rolls are converted and sold by Allegiance, Johnson & Johnson, Kendall Healthcare, American Threshold Industries and others for the hospital, dental, consumer and other institutional markets. Spunlaced fabrics are also produced in Europe and the Far East for a variety of medical and industrial uses. Presently there are 54 commercial producers of spunlaced fabrics in the world. A dramatic expansion is underway in this sector: the market is expected to grow approximately 8% per year for the next several years. [19] The worldwide capacity of spunlacing is increasing. For example, Sontara Technologies (DuPont) expanded its activities in Spain with the start-up of a spunlacing line in late 1998. The new line is able to manufacture spunlaced nonwovens at twice the industry average speed. A huge, full-scale production Miratec line began in December, 1998 at Polymer Group's Benson, NC plant. The Miratec line has some of its technology based on spunlacing. The line is projected to produce $26 million in annual sales. [20] Keeping pace with the increasing production capacity are a wide range of new improved hydroentangling production systems. ICBT Perfojet, France, and Honeycomb Systems, U.S., jointly developed the Jetlace 2000 machine capable of making hydroentangled nonwovens weighing up to 400 gsm. These fabrics are characterized by relatively high tensile strength and abrasion resistance, with softness, drape and conformability approaching that of woven fabrics,.
The hydrolace model developed by Courtaulds
The Aquajet system can be adapted to manufacture spunlaced nonwovens for medical as well as industrial uses. [21] The production plant capabilities are being continuously upgraded with improved quality control for manufacturing high-quality spunlaced fabrics at speeds higher than 150 m/min.
Market data show a 20-25% dollar penetration of spunlaced fabrics into a medical market that formerly used woven gauze exclusively. Medical sponges and bandage rolls utilize approximately one billion square yards of woven and nonwoven fabrics in the United States. The continued increase use of hydroentangled fabrics demonstrates the acceptance by medical professionals and other consumers who have recognized the unique fabric features, desirable functional attributes and economics of spunlaced sponges and bandage rolls. Table 2 reproduced from USP monograph). This is required because the warp and fill threads are usually of standard sizes and weights for each fabric construction type. This facilitates yarn and fabric manufacturing. Medical/surgical nonwoven fabric made from weights by varying the base fiber web weight while the yarn fiber bundle pattern remains constant because of the fixed pattern drum or screen used in the process (refer to Table 3 from reference 22). Most medical/surgical nonwoven fabrics have been designed to replace the common gauze fabrics used for sponges, bandages and dressings. In an attempt to have the nonwoven fabrics appear similar to woven gauze, the fiber bundlers tend to have counts like the woven gauze fabrics. Although the nonwoven fabrics are similar to gauze, the bundle counts are usually not identical because of available screen and drum patterns.
The design and production of medical/surgical nonwoven fabrics for medical end uses may equal or exceed the openness of woven gauze because of the high density of the hydroentangled fiber bundles and their interconnected junctures. The uniformity of the fabric pattern, the open spaces, the stability of fabric openings, the various physical and functional characteristics and the open pattern imparted to the fabric are different than those obtained with plain woven gauze. The fiber bundles may be designed with high density areas that provide a fine capillary structure and allows a rapid absorbency rate or less dense areas with larger capillaries that create low absorbent capacity. Absorbency rates and capacity features are engineered into spunlaced fabrics as performance advantages that are unique to these fabrics. Nonwoven fabrics with well-defined open patterns exhibit physical and performance characteristics equal to or better than those of woven gauze, and they are ideally suited for sponges, dressings and bandage rolls. If medical/surgical nonwoven fabric conforms to the chemical purity and absorbency requirements of the present USP Absorbent Gauze monograph then it is safe to use for all similar products that used USP absorbent gauze.
The physical attributes of medical/surgical nonwoven fabric when made into sponges, dressings and bandage rolls provide improved wicking and greater absorbent capacity than similar Absorbent Gauze products. This may create drier wound sites with less potential for wound infection. Nonwoven dressings made from medical/surgical nonwoven fabrics also produce less lint and fragments which can delay wound healing. When used for post-operative and trauma dressings, surgical nonwoven fabrics are less adherent to wounds than comparable gauze products and may enhance wound healing and patient comfort. Therefore, it is appropriate that medical/surgical nonwoven fabrics should be considered for inclusion into the United States Pharmacopoeia. [22, 23] 
